Voyage: Real-World Impact of the Multi-target Stool DNA Test on CRC Screening and Mortality

Exact Sciences Corporation

Status: Active, not recruiting

Conditions: Colon Cancer

Treatments: Device: Cologuard

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT04124406

2019-08 (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to gather information about the long term health of people who have been prescribed the Cologuard test, which is used for colorectal cancer (CRC) screening.

Full description

Participates will be consented for prospective follow-up for health outcomes, which will be ascertained through periodic contacts. Participants will complete a baseline health questionnaire survey (T0) and a 1-year follow-up questionnaire survey (T1), allow access to medical records, when available, and allow future contacts for additional surveys.

Enrollment: 150,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Resident of the United States
• Age 18 years or older
• Able to provide informed consent
• Able to complete surveys in English or Spanish
• Valid order for Cologuard screening

Exclusion criteria

• N/A

Trial design

150,000 participants in 1 patient group

Adults Prescribed Cologuard

Description:

Adults prescribed Cologuard for routine colon cancer screening by their healthcare provider.

Treatment:

Device: Cologuard